Hemorrhagic stroke associated with antidepressant use in patients with depression: Does degree of serotonin reuptake inhibition matter?

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 3, 2009, Pages 196-202

  Chen, Yan ^a,d   Guo, Jeff J ^a,d   Patel, Nick C ^b,c,d  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b LifeSynch   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d Department of Pharmacoepidemiology ^*

Author keywords

Antidepressant; Case control study; Hemorrhagic stroke; Serotonin

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; NEFAZODONE; PAROXETINE; PHENELZINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISSOCIATION CONSTANT; DRUG CLASSIFICATION; DRUG USE; FEMALE; HEART DISEASE; HEART VENTRICLE HYPERTROPHY; HEMORRHAGIC STROKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RISK FACTOR; SUBSTANCE ABUSE; BRAIN HEMORRHAGE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; FACTUAL DATABASE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CEREBRAL HEMORRHAGE; DATABASES, FACTUAL; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STROKE; UNITED STATES;

EID: 65249144663     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1699     Document Type: Article

References (28)

1. Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997; 8: 517-523.
2. Ramasubbu R. Cerebrovascular effects of SSRIs: a systematic review. J Clin Psychiatry 2004; 65: 1642-1653.
3. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997; 340: 249-258.
4. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. Br Med J 2001; 323: 655-658.
5. Meijer WEE, Heerdink ER, NolenWA, Herings RMC, Leufkens HGM, Egberts ACG. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004; 164: 2367-2370.
6. Movig KLL, Janssen MWHE, de Waal Malefijt J, Kabel PJ, Leufkens HGM, Egberts ACG. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003; 163: 2354-2358.
7. Swenson JR, Doucette S, Fergusson D. Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Can J Psychiatry 2006; 51: 923-929.
8. de Abajo FJ, Jick H, Derby L, Jick SS, Schmitz SM. Intracranial hemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50: 43-47.
9. Bak S, Tsiropoulous I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33: 1465-1473.
10. Chen Y, Guo JJ, Hong L, Wulsin L, Patel NC. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 2008; 42: 177-184.
11. Ramasubbu R, Patten SB. Effect of depression on stroke morbidity and mortality. Can J Psychiatry 2003; 48: 250-257.
12. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998; 158: 1133-1138.
13. Ohira T, Iso H, Satoh S, et al. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 2001; 32: 903-908.
14. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from Baltimore Epidemiologic Catchment Area study. Stroke 2001; 32: 1979-1983.
15. Nilsson FM, Kessing LV. Increased risk of developing stroke for patients with major affective disorder: a registry study. Eur Arch Psychiatry Clin Neurosci 2004; 254: 387-391.
16. Markovitz JH, Shuster JL, Chitwood WS, May RS, Tolbert LC. Platelet activation in depression and effects of sertraline treatment: an open-label study. Am J Psychiatry 2000; 157(6): 1006-1009.
17. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153: 1313-1317.
18. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997; 42: 290-295.
19. Woolorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Can Med Assoc J 2002; 167: 1269-1270.
20. Herrmann N, Lanctot KL. Do atypical antipsychotic cause stroke? CNS Drugs 2005; 19: 91-103.
21. De Clerck F, Somers Y, Van Gorp L. Platelet-vessel wall interactions in hemostasis: implications of 5-hydroxytryptamine. Agents Actions 1984; 15: 627-635.
22. Harrison-Woolrych M, Clark DW. Nose bleeds associated with the use of risperidone. Br Med J 2004; 328: 1416.
23. de Abajo FJ, Garcia Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Br Med J 1999; 319: 1106-1109.
24. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006; 119: 113-116.
25. Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP. Accuracy of diagnostic coding for medicare patients under the prospective payment system. N Engl J Med 1988; 318: 352-355.
26. Tirschwell DL, Longstreth WT. Validating administrative data in stroke research. Stroke 2002; 33: 2465-2470.
27. Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008; 17: 20-26.
28. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001; 43: 453-462.